*Idea: Continued heaviness under VWAP, and continued fails after intial falloff
*Entry: Starter with pops into VWAP as trend held
*Risk: 1:3
Continued falloff from emergency FDA approval. News of Pfizer's manufacturing difficulties may have also been related
N/A
Heavy since yesterday. No guarantees of continued failings but a good sign.
Saw continual heaviness after the small swipes up into the fails. Took a small size, preparing to add in later if it showed further weakness. Was keeping under levels for most of the time, saw the turn into the 138s as a chance to size up but waited to confirm. Saw the strength start building, so got out. First cover at the 137.50s got blown through so out at a minor cut.
You've gotta be ready at the 9:45 mark. If the trade is there, take it. If not, don't. Don't waste time convincing yourself there's something when there isn't.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-12-16 10:38:52 | MRNA | sell | $136.300 | short |
2020-12-16 11:00:25 | MRNA | buy | $137.970 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!